Stock Quotes in this Article: AMRN, ARRY, AVNR, CPRX

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

>>5 Stocks Set to Soar on Bullish Earnings

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

>>5 Breakout Trades for a Santa Claus Rally

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

Avanir Pharmaceuticals

Avanir Pharmaceuticals (AVNR) is a pharmaceutical company focused on acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders. This stock closed up 1.3% to $4.52 in Tuesday's trading session.

Tuesday's Range: $4.38-$4.59

52-Week Range: $2.34-$6.00

Tuesday's Volume: 1.41 million

Three-Month Average Volume: 2.76 million

>>5 Stocks Under $10 Set to Soar

From a technical perspective, AVNR bounced modestly higher here right off its 50-day moving average of $4.42 with lighter-than-average volume. This move is starting to push shares of AVNR within range of triggering a big breakout trade. That trade will hit if AVNR manages to take out some near-term overhead resistance levels at $4.71 to $5.07 with high volume.

Traders should now look for long-biased trades in AVNR as long as it's trending above some near-term support at $4.20 and then once it sustains a move or close above those breakout levels with volume that hits near or above 2.76 million shares. If that breakout hits soon, then AVNR will set up to re-test or possibly take out its 52-week high at $6.

Amarin

Amarin (AMRN) is a biopharmaceutical company that commercializes and develops therapeutics to improve cardiovascular health. This stock closed up 5.9% to $1.95 in Tuesday's trading session.

Tuesday's Range: $1.83-$1.99

52-Week Range: $1.36-$12.90

Tuesday's Volume: 8.08 million

Three-Month Average Volume: 9.08 million

>>5 Rocket Stocks to Buy in December

From a technical perspective, AMRN spiked sharply higher here with decent upside volume. This stock has been uptrending for the last month, with shares moving higher from its low of $1.36 to its intraday high of $1.99. During that move, shares of AMRN have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of AMRN within range of triggering a near-term breakout trade. That trade will hit if AMRN manages to take out Tuesday's high of $1.99 to more near-term resistance at $2.04 with high volume.

Traders should now look for long-biased trades in AMRN as long as it's trending above some key near-term support levels at $1.75 to $1.72 or above $1.45 and then once it sustains a move or close above those breakout levels with volume that hits near or above 9.08 million shares. If that breakout hits soon, then AMRN will set up to re-test or possibly take out its next major overhead resistance levels at $2.24 to $2.45. Any high-volume above $2.45 will then give AMRN a chance to re-fill some of its previous gap down zone from October that started just above $5.

Catalyst Pharmaceutical Partners

Catalyst Pharmaceutical Partners (CPRX) is focused on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. This stock closed flat to $1.87 in Tuesday's trading session.

Tuesday's Range: $1.78-$1.98

52-Week Range: $0.41-$3.65

Tuesday's Volume: 1.62 million

Three-Month Average Volume: 2.20 million

>>5 Stocks Poised for Breakouts

From a technical perspective, CPRX closed off its intraday low of $1.78 to $1.87 with lighter-than-average volume. This stock has been uptrending for the last few weeks, with shares moving higher from its low of $1.29 to its recent high of $2.07. During that move, shares of CPRX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CPRX within range of triggering a near-term breakout trade. That trade will hit if CPRX manages to take out some near-term overhead resistance levels at $2.07 to its 50-day moving average of $2.16 with high volume.

Traders should now look for long-biased trades in CPRX as long as it's trending above some near-term support at $1.63 and then once it sustains a move or close above those breakout levels with volume that's near or above 2.20 million shares. If that breakout hits soon, then CPRX will set up to re-test or possibly take out its next major overhead resistance levels at $2.87 to $3. Any high-volume move above those levels will then give CPRX a chance to re-test its 52-week high at $3.65.

Array BioPharma

Array BioPharma (ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. This stock closed up 3.2% to $5.99 in Tuesday's trading session.

Tuesday's Range: $5.70-$6.00

52-Week Range: $3.41-$7.10

Tuesday's Volume: 2.28 million

Three-Month Average Volume: 1.95 million

From a technical perspective, ARRY spiked higher here right above its 50-day moving average of $5.65 with above-average volume. This move pushed shares of ARRY into breakout territory, since the stock took out some near-term overhead resistance at $5.90. Market players should now look for a continuation move higher in the short-term if ARRY can manage to take out Tuesday's high of $6 with strong volume.

Traders should now look for long-biased trades in ARRY as long as it's trending above its 50-day at $5.65, and then once it sustains a move or close above $6 with volume that hits near or above 1.95 million shares. If we get that move soon, then ARRY will set up to re-test or possibly take out its next major overhead resistance levels at $6.66 to its 52-week high at $7.10.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.

RELATED LINKS:

>>4 Stocks Rising on Big Volume
>>5 Hated Earnings Stocks You Should Love

>>5 Short-Squeeze Stocks Ready to Pop

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.